Blog

A satisfying conclusion to a side-story that became a major project of Livius’ postdoc with Cathy Wu.

Seunghoon Kim, PhD has started his work as shared postdoctoral research fellow between Dr. med. Jana Ihlow and Prof. Sandrine Sander. We are happy to provide the scientific environment in which he will develop his single cell genomics research projects.

Dr. Mischa Selig has started his work as postdoctoral research fellow with us - we are very thrilled to have him and wish him all the best of luck for his projects.

We have an opening for a PhD position.

Exciting times - the first publication from the Penter lab has been released in which we review current studies that employ single cell genomics for performing immune monitoring in blood malignancies.

We are grateful for funding from the DKMS John Hansen Research Grant, which we will utilize to track the beginnings of AML relapse after allogeneic stem cell transplantation.

Welcome Jonas in our lab. Jonas will utilize long-read sequencing and single cell genomics to identify novel immunotherapeutic targets in AML. Good luck!

Welcome Angelos in our lab. Angelos will work on single cell genomics approaches to understand clonal evolution and changes in transcriptional profile.

We have an opening for a postdoctoral research fellow position.

The new year is starting with great news - nanoranger is seeing the light of day!

Maylis TOUMI from Agroparistech in France is joining us for her masters studies in Health Engineering. Maylis will work on distinguishing donor- from recipient-derived single cells. Welcome Maylis!

We have two PhD positions available for projects that will focus on interactions between leukemia and immune cells. In the first project, we will utilize natural genetic barcodes to track leukemia evolution before and after immunotherapeutic bottlenecks such as allogeneic hematopoietic stem cell transplantation. In the second project, we will long-read sequencing to better understand alternative splicing in AML and to use this approach for the identification of novel immunotherapeutic targets. Looking forward to your application!

We are super excited about the news that Else Kröner-Fresenius-Stiftung has decided to fund our proposal to use long-read single cell sequencing technologies to identify novel immunotherapeutic targets in AML/MDS. We’ll soon look for a PhD student who will work on this exciting project. Stay tuned!

Welcome Lena in the Penter lab! Lena will work on biobanking, general lab management and the wet lab side.

We are grateful for research funding from the German Cancer Aid Max-Eder Program that will provide us with a generous start-up package for the first 4 years. Prof. Dr. med. Florian Heidel (Hannover) will serve as mentor for the group - thank you!

We are grateful for research funding from the BIH Charité Digital Clinician Scientist Program that will provide Livius with 50% protected research time for a period of 3 years. A big thank you to Prof. Dr. med. Frederik Damm and Prof. Dr. rer. nat. Nils Blüthgen for supporting the application!